Impact of Surgical Margin Width on Recurrence and Overall Survival Following R0 Hepatic Resection of Colorectal Metastases: A Systematic Review and Meta-analysis
Overview
Authors
Affiliations
Objective: To examine the impact of surgical margin width on survival following R0 hepatic resection for colorectal metastases (CRLM).
Summary Of Background Data: Although negative resection margin is considered of paramount importance for the prognosis of patients with colorectal liver metastases, optimal resection margin width remains controversial.
Methods: Eligible studies examining the association between margin status after R0 hepatic resection for CRLM and survival, including overall survival (OS) and disease-free survival (DFS) were sought using the Medline, Cochrane, and EMBASE databases. Random-effects models were used for the calculation of pooled relative risks (RRs) with their 95% confidence intervals (95% CIs).
Results: Thirty-four studies were deemed eligible for inclusion representing a cohort of 11,147 hepatic resections. Wider resection margin (>1 vs <1 cm) was significantly associated with improved OS at 3 years (pooled RR = 0.86, 95% CI: 0.79-0.95), 5 years (pooled RR = 0.91, 95% CI: 0.85-0.97), and 10 years (pooled RR = 0.94, 95% CI: 0.88-1.00). Similarly, DFS was positively associated with >1 cm resection margin at 3, 5, and 10 years. Interestingly, >1 mm (vs <1 mm) resection margin was significantly associated with improved OS at all-time points. Meta-regression analyses did not reveal any significant modifying role of the study features under investigation, such as the administration of neoadjuvant/adjuvant therapy.
Conclusions: Importantly, our findings suggest that while a >1 mm margin is associated with better prognosis than a submillimeter margin, achieving a margin >1 cm may result in even better oncologic outcomes and should be considered if possible.
Jin Z, Li Y, Yi H, Wang M, Wang C, Du S Int J Oncol. 2025; 66(3).
PMID: 39950314 PMC: 11844340. DOI: 10.3892/ijo.2025.5728.
Li Z, Zhang J, Tian S, Sun C, Ma Y, Ye Z Ann Surg Oncol. 2025; .
PMID: 39907877 DOI: 10.1245/s10434-025-16941-6.
Paramythiotis D, Karlafti E, Tsavdaris D, Apostolidou Kiouti F, Haidich A, Ioannidis A J Clin Med. 2025; 13(24.
PMID: 39768699 PMC: 11727772. DOI: 10.3390/jcm13247776.
Liu Y, Lun H, Huang X, Huang J, Zhu S Int J Gen Med. 2024; 17:5817-5824.
PMID: 39654984 PMC: 11627102. DOI: 10.2147/IJGM.S491165.
Zheng J, Wang T, Wang H, Yan B, Lai J, Qiu K Ann Surg Oncol. 2024; 32(2):771-782.
PMID: 39614006 DOI: 10.1245/s10434-024-16519-8.